Company: UPC
Filing Date: 2025-09-03
Form Type: 6-K
Source: 0001213900-25-084040
Chunk: 2

Company: Universe Pharmaceuticals INC
Filing Date: 2025-09-03
Form: 6-K
Chunk 2
---
;

to US$20,000 divided into 2,000,000,000
ordinary shares of par value US$0.00001 each

(the “Capital Alteration”);

| e) | immediately                       
 following the Capital Alteration: |

| a. | the                                                                                                 
 authorised and issued share capital of the Company be divided into two separate classes as follows: |

| i. | US$18,000                                                                                                            
 divided into 1,800,000,000 class A ordinary shares of par value US$0.00001 each (the “Class A Ordinary Shares”); and |

| ii. | US$2,000                                                                                                                   
 divided into 200,000,000 class B ordinary shares of par value US$0.00001 each (the “Class B Ordinary Shares” and, together 
 with the Class A Ordinary Shares, the “New Share Classes”),                                                                |

<div align='center'>2</div>

it being noted that the terms of, and rights attaching to
the New Share Classes will be materially identical to the existing ordinary shares of par value US$0.00001 each in the capital of the
Company save that the Class B Ordinary Shares: (i) shall have 100 times the voting rights per share of Class A Ordinary Shares; and (ii)
shall be convertible into Class A Ordinary Shares;

| b. | the                                                                                                     
 issued shares in the Company outstanding following the Capital Alteration be re-designated, as follows: |

| i. | the                                                                                                                         
 559,868 ordinary shares of par value US$0.00001 each held by Cede & Co be re-designated as 559,868 Class A Ordinary Shares; |

| ii. | the                                                                                                            
 1 ordinary share of par value US$0.00001 held by Christopher Lin be re-designated as 1 Class A Ordinary Share; |

| iii. | the                                                                                                          
 1 ordinary share of par value US$0.00001 held by Michael Olson be re-designated as 1 Class A Ordinary Share; |

| iv. | the                                                                                                                 
 1 ordinary share of par value US$0.00001 held by Daniel J Sleiman be re-designated as 1 Class A Ordinary Share; and |

| v. | the                                                                                                                                  
 3,467 ordinary shares of par value US$0.00001 each held by Sununion Holding Group Limited be re-designated as 3,467 Class B Ordinary 
 Shares,